Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CCR2 | P41597 | 2/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | CPB1 | P15086 | 1/20 | 0.36 |
| ▸ | CCR5 | P51681 | 3/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5033700 | 0.86 | CCR2 (0.44) | SIGMAR1CYP2D6CCR2KCNH2CPB1 | |
| SCHEMBL5029286 | 0.79 | ALDH1A1 (0.52) | CYP3A4TSHRCYP2D6CCR2KCNH2 | |
| SCHEMBL5030522 | 0.75 | CCR2 (0.44) | CYP2D6CCR2KCNH2CPB1CCR5 | |
| Trifluoroacetic Acid SCHEMBL5030519 | 0.74 | CCR2 (0.53) | CYP3A4TSHRCYP2D6CCR2KCNH2 | |
| SCHEMBL5029509 | 0.71 | CPB1 (0.49) | CYP3A4TSHRCYP2D6CCR2KCNH2 | |
| SCHEMBL21501961 | 0.71 | CYP3A4 (0.43) | SIGMAR1CYP3A4TSHRCYP2D6CCR2 | |
| SCHEMBL5029168 | 0.70 | CPB1 (0.36) | SIGMAR1TSHRCPB1CHRM2CHRM5 | |
| SCHEMBL1058888 | 0.68 | SIGMAR1 (0.60) | SIGMAR1TSHRCCR5CHRM2CHRM5 | |
| SCHEMBL5027262 | 0.68 | CPB1 (0.34) | SIGMAR1CYP3A4TSHRCYP2D6CPB1 | |
| SCHEMBL504662 | 0.68 | CCR6 (0.46) | SIGMAR1CHRM2CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7378409-B2 | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-05-27 | — | — | US | disclosed |
| US-20050054626-A1 | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY | 2005-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054626-A1 | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity | CCL11, CCR1, CCR2 | SIGMAR1 718/4885CYP3A4 3690/4885TSHR 1726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.